cas 2109553-33-3|| where to buy 5-cyclobutyl-1,3-oxazole

Nom du produit:5-cyclobutyl-1,3-oxazole

IUPAC Name:5-cyclobutyl-1,3-oxazole

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM413283-1g	5-6 Weeks	ǵǤǵǵ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2109553-33-3 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2109553-33-3; Formule moléculaire:C7H9NO; Point de fusion:-; Code SMILES:C1CC(C1)C1=CN=CO1; Densité:

: Numéro de catalogue:CM413283; Poids moléculaire:123.16; Point d'ébullition:; N° Mdl:MFCD31666791; Stockage:

: Oxazoles; Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.